tirzepatide and heart issues 💊 New research in obesity & failure The SUMMIT study looked at tirzepatide, a once-weekly injection, in people with both obesity heart failure with preserved ejection fraction (HFpEF). Over 52 Tirzepatide and Cardiovascular Outcomes in

Novo Nordisk has defended disappointing trial results for its much-hyped next generation obesity drug candidate CagriSema, insisting it will be an "important" weight loss treatment

Sources: Lillys oral GLP-1, Orforglipron, delivers weight loss of up to an average of 27.3 lbs in first of two pivotal phase 3 trials in adults with obesity | Eli Lilly and Company

Eating water-rich foods like fruits and vegetables can also contribute to your daily water intake

They also reduce the uncomfortable side effects of quitting, like cravings, withdrawal symptoms, and overeating

The Temecula Valley AVA , established in 1984, is about 60 miles north of San Diego and 90 miles southeast of Los Angeles

Reddit threads and TikTok have been flooded with guys using these "tan jabs" as a shortcut to achieving a sun-kissed look